{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:02:58Z","timestamp":1777604578572,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) associated with concurrent portal vein tumour thrombus (PVTT) and bile duct tumour thrombus (BDTT) is sporadic and presents a puzzle to management with miserable prognostic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>The authors reported a case of HCC in the right liver with PVTT involving the right portal vein and BDTT developing in the common bile duct, detected in a 43-year-old man. The patient was admitted to our hospital with abdominal pain in the right hypochondrium and obstructive jaundice. Imaging studies showed a large mass in the right liver with invasion of the first branch of the portal vein and dilated intrahepatic bilateral bile ducts. A liver biopsy confirmed the diagnosis of hepatocellular carcinoma. Right hepatectomy plus thrombectomy en bloc with extrahepatic bile duct resection was performed. Subsequently, the patient received a postoperative adjuvant transarterial chemoembolization (PA-TACE) 1 month after surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>In the present case, the authors were not aiming for curative treatment by aggressive management but for palliative treatment. At the time of diagnosis, the tumour had already invaded the portal bifurcation. Hepatectomy plus thrombectomy en bloc with resection of common bile duct can remove biliary obstruction caused by BDTT, optimize portal flow by eliminating PVTT, and reduce the tumour burden, consequently improving the quality of life and liver function. Then, PA-TACE takes care of microfoci left behind by the surgery, which may prolong survival time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>An aggressive therapeutic strategy should be considered in exceptional cases for resectable HCC with PVTT and obstructive BDTT. However, the follow-up period remains limited. A longer duration of observation is necessary to definitively assess the surgery\u2019s impact on patient\u2019s recurrence and survival time.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002035","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T17:26:59Z","timestamp":1717522019000},"page":"3667-3673","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Surgical management for hepatocellular carcinoma with concurrent portal vein tumour thrombus and bile duct tumour thrombus: a case report"],"prefix":"10.1097","volume":"86","author":[{"given":"Anh The","family":"Pham","sequence":"first","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trung","family":"Duc Vu","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thinh Duy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging, Thanh Nhan Hospital, Hanoi, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuong Manh","family":"Truong","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh Viet","family":"Pham","sequence":"additional","affiliation":[{"name":"Anesthesia and Resuscitation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toan","family":"Quang Vu","sequence":"additional","affiliation":[{"name":"Internal Medical 3, Vietnam National Cancer Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.hbpd.2021.12.004","article-title":"Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: a narrative review","volume":"21","author":"Tao","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000658-200103000-00012","article-title":"Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus","volume":"233","author":"Minagawa","year":"2001","journal-title":"Ann Surg"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1097\/MD.0000000000000364","article-title":"Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery","volume":"94","author":"Zeng","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00268-015-2985-9","article-title":"Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion","volume":"39","author":"Kasai","year":"2015","journal-title":"World J Surg"},{"key":"R5-20250806","first-page":"1136","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","journal-title":"Int J Surg Lond Engl 2023"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","article-title":"Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan","volume":"37","author":"Ikai","year":"2007","journal-title":"Hepatol Res"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jso.20260","article-title":"Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus","volume":"90","author":"Esaki","year":"2005","journal-title":"J Surg Oncol"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/hpb.12368","article-title":"Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus","volume":"17","author":"Wong","year":"2015","journal-title":"HPB Oxf"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/cncr.20426","article-title":"Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey","volume":"101","author":"Ikai","year":"2004","journal-title":"Cancer"},{"key":"R13-20250806","first-page":"673","article-title":"Case records of the Massachusetts General Hospital","volume":"237","author":"Mallory","year":"1947","journal-title":"Engl J Med"},{"key":"R14-20250806","first-page":"267","article-title":"Icteric type hepatoma","volume":"4","author":"Lin","year":"1975","journal-title":"Med Chir Dig"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.3748\/wjg.v26.i44.7005","article-title":"Hepatocellular carcinoma with tumor thrombus in bile duct: a proposal of new classification according to resectability of primary lesion","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.hpb.2015.12.003","article-title":"Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus","volume":"18","author":"Navadgi","year":"2016","journal-title":"HPB (Oxford)"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/hpb.12383","article-title":"Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?","volume":"17","author":"Rammohan","year":"2015","journal-title":"HPB (Oxford)"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00268-004-7185-y","article-title":"Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi","volume":"28","author":"Yeh","year":"2004","journal-title":"World J Surg"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O","article-title":"Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma","volume":"89","author":"Poon","year":"2000","journal-title":"Cancer"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.2147\/CMAR.S270467","article-title":"Postoperative adjuvant transarterial chemoembolization improves short-term prognosis of hepatocellular carcinoma with bile duct tumor thrombus: a propensity-score matching study","volume":"12","author":"Huang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.7150\/ijbs.46896","article-title":"Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable hepatocellular carcinoma with portal vein tumor thrombus after liver resection","volume":"16","author":"Liu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00270-019-02392-6","article-title":"Resection plus post-operative adjuvant transcatheter arterial chemoembolization (TACE) compared with resection alone for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"43","author":"Huo","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00432-012-1343-7","article-title":"Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection","volume":"139","author":"Chen","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejso.2017.11.022","article-title":"The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review","volume":"44","author":"Glantzounis","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.29883","article-title":"Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies","volume":"68","author":"Hyun","year":"2018","journal-title":"Hepatology"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/hep.30490","article-title":"An Eastern Hepatobiliary Surgery Hospital\/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study","volume":"69","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"1756284820977693","DOI":"10.1177\/1756284820977693","article-title":"Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"Liang","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1002\/ijc.29203","article-title":"Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis","volume":"136","author":"Zheng","year":"2015","journal-title":"Int J Cancer"},{"key":"R31-20250806","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JHC.S352480","article-title":"Postoperative adjuvant transarterial chemoembolization plus tyrosine kinase inhibitor for hepatocellular carcinoma: a multicentre retrospective study","volume":"9","author":"Lin","year":"2022","journal-title":"J Hepatocell Carcinoma"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:12:24Z","timestamp":1754485944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002035","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"2024-02-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}